The federal government has granted provisional approval for the R21/Matrix malaria vaccine developed by scientists at Oxford University. Mojisola Adeyeye, director-general of the National Agency for Food and Drug Administration
Tag "Provisional approval"
Advertisement
Advertisement
Advertisement
Advertisement
Top Stories
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Life and Living
Advertisement
Advertisement